Cagrilintide Safety and Risks As with any investigational peptide , cagrilintide should be used with clinical caution , particularly in populations with pre-existing endocrine or gastrointestinal disorders
Do not inject where the skin has pits, is thickened, or has lumps
About 430 million of the world population is affected by diabetes
If you experience stomach burning, dizziness, or fluid retention, stop the ibuprofen immediately
Characteristics of Suitable Candidates Adults with uneven skin tone, hyperpigmentation, or melasma who have not responded adequately to topical treatments People with dull or sun-damaged skin seeking a non-surgical brightening approach Individuals in good general health with no contraindicated conditions Patients with realistic expectations who understand results require a course of sessions and maintenance Who Should Not Have This Treatment What Are the Side Effects and Risks of Glutathione Injections
Frequently Asked Questions Can you stop taking GLP-1 medications once you reach your target weight